Non-Peptidic, Non-Prenylic Bisubstrate Farnesyltransferase Inhibitors. Effect of a Carboxyl Group at the Central Group on Farnesyltransferase Inhibitory Activity

Author： Schlitzer M. Sattler I.

Publisher： Pharmaceutical Press

ISSN： 1460-8081

Source： Pharmacy and Pharmacology Communications, Vol.6, Iss.11, 2000-11, pp. : 507-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-peptidic, Non-prenylic Bisubstrate Farnesyltransferase Inhibitors, 4. Effect on Farnesyltransferase Inhibitory Activity of Conformational Restrictions in the Central Group

By Schlitzer M. Sattler I.

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 3, 2000-03 ,pp. : 117-124

Pharmaceutical Press

Access to resources Recommend Favorite

New Non-peptidic Inhibitors of Ras Farnesyltransferase

By Salaun M.C. Deweer S. Goossens J.F. Houssin R. Pommery J. Hénichart J.P.

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 3, 1999-03 ,pp. : 173-176

Pharmaceutical Press

Access to resources Recommend Favorite

Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors

By Schlitzer M. Sattler I.

European Journal of Medicinal Chemistry, Vol. 35, Iss. 7, 2000-08 ,pp. : 721-726

Elsevier

Access to resources Recommend Favorite

Non-peptidic chymase inhibitors

By Aoyama Yasunori

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1423-1428

Informa Healthcare

Access to resources Recommend Favorite

Non-Peptidic HIV Protease Inhibitors

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-06 ,pp. : 1097-1114

Bentham Science Publishers

Access to resources Recommend Favorite